|
Huons a pharmaceutical subsidiary of Huons Group announced on November 28th that it received phase 1 Clinical Study Result (CSR) for ‘HUC1-394’ eye drop on the 27th.
HUC1-394 is a peptide-based eye drop for dry eyes, licensed from NOVACELL Technology Inc. The drug selectively binds to ‘Formyl Peptide Receptor 2 (FPR2)’, which controls and reduces inflammation, then activates FPR2 to reduce and alleviate inflammation.
Clinical trial results confirmed the safety and tolerability of single- and multiple-dose escalation study of HUC1-394. There was no Serious Adverse Event (SAE). Most of Treatment Emergent Adverse Events (TEAE) were in grade 1 (mild) and recovered within the observation period. It was determined that there was no close correlation between category and frequency of TEAE and dose and period of HUC1-394 administration.
Huons will analyze the clinical trial results and conduct follow-up clinical trial.
Huons Vice President and Head of R&D Kyung-mi Park said “I am very proud to confirm the safety and tolerability of the HUC1-394 eye drop in Phase 1 clinical trial. We expect to be able to provide new treatment option for dry eye syndrome through follow up clinical trial.”





![[포토] 겨울 과일 '석류' 출시](https://image.edaily.co.kr/images/Photo/files/NP/S/2026/11/PS26112000721t.jpg)
![[포토] 크리스마스 맞이하는 롯데타운](https://image.edaily.co.kr/images/Photo/files/NP/S/2026/11/PS26111900800t.jpg)
![[포토]'모두발언하는 장동혁 대표'](https://image.edaily.co.kr/images/Photo/files/NP/S/2026/11/PS26111900565t.jpg)
![[포토]잘하고 와](https://image.edaily.co.kr/images/Photo/files/NP/S/2026/11/PS26111900485t.jpg)
![[포토]코브(Kove), 모터스포츠 DNA를 담았다](https://image.edaily.co.kr/images/Photo/files/NP/S/2026/11/PS26111701091t.jpg)
![[포토]청와대 앞에서 열린 국민의힘 현장 최고위원회의](https://image.edaily.co.kr/images/Photo/files/NP/S/2026/11/PS26111600393t.jpg)
![[포토]가을의 끝자락](https://image.edaily.co.kr/images/Photo/files/NP/S/2026/11/PS26111500330t.jpg)
![[포토]수험생 응원 메시지가 가득 담긴 조계사 소원지](https://image.edaily.co.kr/images/Photo/files/NP/S/2026/11/PS26111500310t.jpg)
![[포토]기름값 26주 하락](https://image.edaily.co.kr/images/Photo/files/NP/S/2026/11/PS26111500292t.jpg)
![[포토]'표정 어두운 김민석 대표'](https://image.edaily.co.kr/images/Photo/files/NP/S/2026/11/PS26111300806t.jpg)


